Two Sigma Advisers
GILD icon

Two Sigma Advisers’s Gilead Sciences GILD Stock Holding History

Two Sigma Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-82,000
Closed -$6.8M – 2450
2014
Q2 		$6.8M Buy
82,000
+71,000
+645% +$5.53M 0.05% 383
2014
Q1 		$779K Buy
+11,000
New +$863K 0.01% 1302
2013
Q4 		– Sell
-59,000
Closed -$3.71M – 2397
2013
Q3 		$3.71M Buy
59,000
+39,000
+195% +$2.33M 0.04% 416
2013
Q2 		$1.02M Buy
+20,000
New +$1.04M 0.01% 854

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Two Sigma Advisers's GILD Position: Q1 2026 in Review

Two Sigma Advisers sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 52,000 shares — an estimated $6.38M sold.

Two Sigma Advisers first reported a position in GILD in Q2 2013 and held it in 48 quarters. The position peaked at $434M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Two Sigma Advisers reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 52,000 Gilead Sciences shares in Q1 2026, an estimated $6.38M.
  • Two Sigma Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 48 quarters.
  • Two Sigma Advisers's Gilead Sciences position peaked at $434M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.